CA3256695A1 — Treatments with nirogacestat
Assigned to SpringWorks Therapeutics Inc · Expires 2023-11-23 · 2y expired
What this patent protects
The present disclosure relates to improved methods of treatment with nirogacestat. The present invention further includes improvement methods of treating conditions responsive to inhibition of gamma secretase, such as desmoid tumor, multiple myeloma, ovarian granulosa cell tumors…
USPTO Abstract
The present disclosure relates to improved methods of treatment with nirogacestat. The present invention further includes improvement methods of treating conditions responsive to inhibition of gamma secretase, such as desmoid tumor, multiple myeloma, ovarian granulosa cell tumors, with nirogacestat and pharmaceutically acceptable salts thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.